Cellectis (CLLS) Reports Q2 Loss of EUR0.23/Share

September 8, 2016 5:34 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Cellectis (NASDAQ: CLLS) reported Q2 EPS of (EUR0.23), versus (EUR0.43) reported last year. Revenue for the quarter came in at EUR18.14 million, versus EUR8 million reported last year.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment